Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
2009 StandoutNobel
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
The role of paid work in Swedish chronic dialysis patients—a nation‐wide survey: paid work and dialysis
1991
Renal cell carcinoma in uremic acquired renal cystic disease: Incidence, detection, and management
1991
Lipid lowering with PCSK9 inhibitors
2014
Insulin-Like Growth Factor I Plays a Role in Regulating Erythropoiesis in Patients with End-Stage Renal Disease and Erythrocytosis
1999
Targeting PCSK9 for Therapeutic Gains
2015
Renal cell carcinoma in patients withend-stage renal disease: A comparison of clinical significance in patients receiving hemodialysis and those with renal transplants
1994
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial
2013
Development of vaccines and antivirals for combating viral pandemics
2020 StandoutNobel
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
2016 StandoutNobel
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial
2010 StandoutNobel
New Insights into the Biology of Renal Cell Carcinoma
2011 StandoutNobel
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
2015
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
2006
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
2007
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
2013
Screening for acquired cystic kidney disease: A decision analytic perspective
1995
An Ultrasound Renal Cyst Prevalence Survey: Specificity Data for Inherited Renal Cystic Diseases
1993
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
2021 StandoutNobel
Chronic kidney disease
2011 Standout
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Pathologic Classification of Diabetic Nephropathy
2010 Standout
Non-viral vectors for gene-based therapy
2014 Standout
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Atherosclerosis
2019 Standout
Renal Cell Carcinoma in Transplant Recipients with Acquired Cystic Kidney Disease
2007
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
2016
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
VHL-gene Deletion in Single Renal Tubular Epithelial Cells and Renal Tubular Cysts: Further Evidence for a Cyst-dependent Progression Pathway of Clear Cell Renal Carcinoma in von Hippel-Lindau Disease
2010
The Severe Hypercholesterolemia Phenotype
2014
Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease
2017 Standout
Insights into bombesin receptors and ligands: Highlighting recent advances
2015
Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
2016
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function
2019
Degradation from the outside in: Targeting extracellular and membrane proteins for degradation through the endolysosomal pathway
2021 StandoutNobel
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout
Long‐term quality of life after kidney and simultaneous pancreas–kidney transplantation
1998
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function
2019
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
1995
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL −/− clear cell renal carcinoma
2017 StandoutNobel
Renal Replacement Therapy in Type 2 Diabetic Patients: 10 Years' Experience
1992
Targeting PCSK9 for Hypercholesterolemia
2013
Progress In The Development Of Anti-Hepatitis C Virus Nucleoside And Nucleotide Prodrugs
2012
Renal cell carcinoma in autosomal dominant polycystic kidney disease.
1994
Changes in quality of life after hormonal treatment of endometriosis
2001 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
2020 Standout
Diabetic Kidney Disease
2017 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The discovery of diabetic nephropathy: from small print to centre stage.
2006
Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
2016
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Approved Antiviral Drugs over the Past 50 Years
2016
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
2020
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
2020 Standout
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
The VHL Tumor Suppressor Gene: Insights into Oxygen Sensing and Cancer.
2017 StandoutNobel
Peficitinib: First Global Approval
2019
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
Diverse Effects of Mutations in Exon II of the von Hippel-Lindau (VHL) Tumor Suppressor Gene on the Interaction of pVHL with the Cytosolic Chaperonin and pVHL-Dependent Ubiquitin Ligase Activity
2002 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Works of Mark Matson being referenced
Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
2012
Transplantation, hemodialysis, and continuous ambulatory peritoneal dialysis for end-stage renal disease in diabetic patients
1988
Acquired Cystic Kidney Disease
1990
Pharmacokinetics and Pharmacodynamics of MK‐5046, a Bombesin Receptor Subtype‐3 (BRS‐3) Agonist, in Healthy Patients
2011
AB0364 Pharmacokinetics, safety, and tolerability of asp015k, a novel janus kinase inhibitor, in healthy volunteers
2013
Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers
2011
Long-term Follow-up of 369 Diabetic Patients Undergoing Dialysis
1988
460 A STUDY OF THE SAFETY AND PHARMACOKINETICS OF SINGLE ASCENDING ORAL DOSES OF INX-08189, A NUCLEOTIDE POLYMERASE INHIBITOR, IN HEALTHY SUBJECTS
2011
Pharmacokinetics, Pharmacodynamics, and Safety of ASP015K (Peficitinib), a New Janus Kinase Inhibitor, in Healthy Subjects
2016